tradingkey.logo
tradingkey.logo
Suchen

Niagen Bioscience Inc

NAGE
Zur Watchlist hinzufügen
3.430USD
+0.100+3.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
273.42MMarktkapitalisierung
14.69KGV TTM

mehr Informationen über Niagen Bioscience Inc Unternehmen

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Niagen Bioscience Inc Informationen

BörsenkürzelNAGE
Name des UnternehmensNiagen Bioscience Inc
IPO-datumJun 25, 2007
CEOFried (Robert N)
Anzahl der mitarbeiter104
WertpapierartOrdinary Share
GeschäftsjahresendeJun 25
Addresse10900 Wilshire Blvd Suite 600
StadtLOS ANGELES
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl90024
Telefon13103886706
Websitehttps://www.niagenbioscience.com/
BörsenkürzelNAGE
IPO-datumJun 25, 2007
CEOFried (Robert N)

Führungskräfte von Niagen Bioscience Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
9.59K
+23.15%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Niagen Bioscience Inc?

Die fünf größten Anteilseigner von Niagen Bioscience Inc sind: Mr. Ozan Pamir